An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia
Clinical trial NCT03604705 · COMPLETED
Trial details
- NCT number
- NCT03604705
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-03
- Primary completion
- 2020-03-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.